Evidence map›Paper›PMID 21859082›Full record

ArticleJournal of natural products2011

Stereochemical analysis of leubethanol, an anti-TB-active serrulatane, from Leucophyllum frutescens.

Gloria M Molina-Salinas, Verónica M Rivas-Galindo, Salvador Said-Fernández, David C Lankin, Marcelo A Muñoz, Pedro Joseph-Nathan, Guido F Pauli, Noemí Waksman

Abstract read
In one paragraph

Article in Journal of natural products, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Biological Potential of Silver Nanoparticles Mediated byNanomaterials (Basel, Switzerland) · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Quantitative Aspect ofJournal of analytical methods in chemistry · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gloria M Molina-SalinasDepartment of Analytical Chemistry, Faculty of Medicine, Universidad Autónoma de Nuevo Leon, P.O. Box 2316, Sucursal Tecnológico, Monterrey, N.L., 64841 Mexico.
Verónica M Rivas-Galindo
Salvador Said-Fernández
David C Lankin
Marcelo A Muñoz
Pedro Joseph-Nathan
Guido F Pauli
Noemí Waksman

Funding

900MHz NMR for Structural Biology in ChicagoP41GM068944 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GETTINS, PETER G.W. · 2003 to 2007
$6.2M
NIGMS NIH HHS GM068944NIGMS NIH HHS P41 GM068944
6 · The paper itself

Abstract

Bioactivity-guided fractionation of the methanolic root bark extract of Leucophyllum frutescens led to the identification of leubethanol (1), a new serrulatane-type diterpene with activity against both multi-drug-resistant and drug-sensitive strains of virulent Mycobacterium tuberculosis. Leubethanol (1) was identified by 1D/2D NMR data, as a serrulatane closely related to erogorgiane (2), and exhibited anti-TB activity with minimum inhibitory concentrations in the range 6.25-12.50 μg/mL. Stereochemical evidence for 1 was gleaned from 1D and 2D NOE experiments, from 1H NMR full spin analysis, and by comparison of the experimental vibrational circular dichroism (VCD) spectrum to density functional theory calculated VCD spectra of two diastereomers.

Indexed as

Antitubercular AgentsCircular DichroismDiterpenesMexicoMolecular StructureMycobacterium tuberculosisNuclear Magnetic Resonance, BiomolecularPlant BarkPlant RootsScrophulariaceaeAntitubercular AgentsDiterpeneserogorgianeleubethanol

Identifiers

PMID21859082
PMCPMC3600946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.